Molecular and cellular mechanisms of cardiotoxicity

被引:67
作者
Kang, YJ
机构
[1] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40202 USA
[2] Univ Louisville, Sch Med, Dept Pharmacol, Louisville, KY 40202 USA
[3] Univ Louisville, Sch Med, Dept Toxicol, Louisville, KY 40202 USA
[4] Jewish Hosp Heart & Lung Inst, Louisville, KY USA
关键词
apoptosis; cardiac hypertrophy; cardiomyopathy; cytokines; gene regulation; heart failure; MAPK; necrosis; PKC; transcription factors;
D O I
10.2307/3434844
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Cardiotoxicity resulting from detrimental environmental insults has been recognized for a long time. However, extensive studies of the mechanisms involved had not been undertaken until recent years. Advances in molecular biology provide powerful tools and make such studies possible. We are gathering information about cellular events, signaling pathways, and molecular mechanisms of myocardial toxicologic responses to environmental toxicants and pollutants. Severe acute toxic insults cause cardiac cell death instantly. In the early response to mild environmental stimuli, biochemical changes such as alterations in calcium homeostasis occur. These may lead to cardiac arrhythmia, which most often is reversible. Prolonged stimuli activate transcription factors such as activator protein-1 through elevation of intracellular calcium and the subsequent activation of calcineurin. Upregulation by activated transcription factors of hypertrophic genes results in heart hypertrophy, which is a short-term adaptive response to detrimental factors. However, further development of hypertrophy will lead to severe and irreversible cardiomyopathy, and eventually heart failure. From cardiac hypertrophy to heart failure, myocardial cells undergo extensive biochemical and molecular changes. Cardiac hypertrophy causes tissue hypoperfusion, which activates compensatory mechanisms such as production of angiotensin II and norepinephrine. Both further stimulate cardiac hypertrophy and, importantly, activate counterregulatory mechanisms including overexpression of atrial natriuretic peptide and b-type natriuretic peptide, and production of cytokines such as tumor necrosis factor-alpha. This counterregulation leads to myocardial remodeling as well as cell death through apoptosis and necrosis. Cell death through activation of mitochondrial factors and other pathways constitutes an important cellular mechanism of heart failure. Our current knowledge of cardiotoxicity is limited. Further extensive studies are warranted for a comprehensive understanding of this field.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 168 条
[1]   Mitochondrial ATP production is necessary for activation of the extracellular-signal-regulated kinases during ischaemia/reperfusion in rat myocyte-derived H9c2 cells [J].
Abas, L ;
Bogoyevitch, MA ;
Guppy, M .
BIOCHEMICAL JOURNAL, 2000, 349 (01) :119-126
[2]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[3]   QUANTITATIVE STRUCTURAL-ANALYSIS OF THE MYOCARDIUM DURING PHYSIOLOGICAL GROWTH AND INDUCED CARDIAC-HYPERTROPHY - A REVIEW [J].
ANVERSA, P ;
RICCI, R ;
OLIVETTI, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (05) :1140-1149
[4]  
ANVERSA P, 1991, LAB INVEST, V64, P441
[5]  
Balasubramanyam M, 2000, Indian Heart J, V52, P226
[6]   The role of protein kinases in adaptational growth of the heart [J].
Bogoyevitch, MA ;
Sugden, PH .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1996, 28 (01) :1-12
[7]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[8]   PROTOONCOGENE EXPRESSION IN PORCINE MYOCARDIUM SUBJECTED TO ISCHEMIA AND REPERFUSION [J].
BRAND, T ;
SHARMA, HS ;
FLEISCHMANN, KE ;
DUNCKER, DJ ;
MCFALLS, EO ;
VERDOUW, PD ;
SCHAPER, W .
CIRCULATION RESEARCH, 1992, 71 (06) :1351-1360
[9]  
Buck ED, 1999, J PHARMACOL EXP THER, V289, P477
[10]  
CHALLICE CE, 1973, ULTRASTRUCTURE MAMMA